Polymer-Protein Core-Shell Nanoparticles for Vaccine Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine delivery methods fail to effectively enhance immune responses due to limitations in size, repetitive structure, and epitope density, which are crucial for generating robust protective immunity.
Innovation Solution
The development of polymer-protein core-shell nanoparticles, where a pyridinyl group grafted polymer assembles with proteins or glycoproteins to form core-shell particles, enhancing immune responses through increased contact superficial area and epitope density.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vaccine delivery methods are used, then the vaccine can be administered, but the immune response is not sufficiently enhanced due to limitations in size, repetitive structure, and epitope density
Solution Approach 1:
The vaccine particle is segmented into a core-shell structure where the core contains the antigen and the shell provides immune-modulatory properties. This segmentation allows optimization of each component's function independently, enhancing immune response while managing complexity through modular design.
Solution Approach 2:
The invention uses composite materials combining polymer components with antigen proteins to form core-shell particles. The polymer shell provides structural stability and immune modulation, while the core contains the antigen, creating a composite structure that enhances overall vaccine efficacy through synergistic properties.
2Area of stationary object
If the particle size is increased to enhance immune response, then epitope density and contact surface area improve, but the particle may become too large for effective cellular uptake
Solution Approach 1:
The invention transitions from flat, two-dimensional antigen presentations to three-dimensional core-shell particles. This dimensional change increases the contact surface area and epitope density without proportionally increasing the linear dimensions, allowing enhanced immune recognition while maintaining optimal particle size for cellular uptake.
Solution Approach 2:
The core-shell structure nests the antigen-containing core within the polymer shell. This nested arrangement maximizes the use of internal space, allowing high epitope density within the core while the shell provides additional surface area for immune interaction without excessive overall size increase.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These nanoparticles significantly enhance IgG responses and promote robust immune reactions, demonstrating stability and efficacy in in vivo studies without causing toxicity, effectively delivering antigens to immune cells.
Implementation Method 1
a pyridinyl group grafted polymer assembled with a protein or a glycoprotein based antigen to form a core-shell particle
Data Source
AI summary
A polymer-protein core-shell nanoparticle is generally provided. In one embodiment, the polymer-protein core-shell nanoparticle includes a pyridinyl group grafted polymer assembled with a protein or a glycoprotein based antigen to form a core-shell particle. A method is also generally provided for treating an infected organism. In one embodiment, the method includes administering the polymer-protein core-shell nanoparticle to the infected organism.